Trump’s pick for HHS Secretary, acted as medical stocks, while in Congress

17. March 2015: Rep. Tom Price, R-Ga. the house budget announces during a press conference on Capitol Hill in Washington.

(Reuters/Joshua Roberts)

President-elect Donald Trump’s pick to run the health and Human Services Department traded more than 300,000 $in stocks of health-related companies in the past four years, while the sponsorship and support of legislation that potentially impact on this company’s shares.

Rep. Tom Price, R-Ga., bought and sold stock in over 40 health-care, pharmaceutical and biomedical companies since 2012, including a dozen in the current congressional session, according to a Wall Street Journal review of hundreds of pages of the stock-trade, he at the Congress.

In the same two-year period, he has sponsored and co-sponsored by 35 health-related bills in the house.

Its shares trade include Amgen, Bristol-Meyers Squibb, Eli Lilly, Pfizer and Aetna.

His largest single stock purchase was a August 2016 purchase of between $50,000 and $100,000 from an Australian biomedical company, Innate immune therapeutics, whose largest shareholder is a GOP Congresswoman on the trump-transition team, according to the applications, the list of price classes. The stock has since doubled in price.

Click for more from the Wall Street Journal

Follow us

Don't be shy, get in touch. We love meeting interesting people and making new friends.

Most popular